Form 4 for KMDA KAMADA LTD
Accepted 2026-09-17 11:40:16 ET · period of report 2026-09-14 · accession 0001213900-26-100845 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-09-17 11:40 | 2026-09-14 | KMDA | Brenner Yael | VP Quality | M - OptEx | $5.93 | +27.0K | 11.7K | New | +$159.9K |
| DM | 2026-09-17 11:40 | 2026-09-14 | KMDA | Brenner Yael | VP Quality | F - Tax | $8.36 | -7,395 | 6,266 | -54% | -$61.8K |
| DMI | 2026-09-17 11:40 | 2026-09-14 | KMDA | Brenner Yael | VP Quality | M - OptEx | $0.00 | -27.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-09-14 | M | A | 5,000 | $5.93 | 11,266 | D | — | — | (F1) All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 14, 2026. |
| 2 | Common | Ordinary Shares | 2026-09-14 | F | D | 1,371 | $8.36 | 6,266 | D | — | — | (F2) Represents a "net exercise" of outstanding stock options. The reporting person received 1,371 ordinary shares on net exercise of option to purchase 5,000 ordinary shares. The Company withheld 3,629 ordinary shares underlying the option for payment of the exercise price and tax withholdings, using the closing stock price on September 14, 2026 of $8.36, pursuant to the terms of the Company's 2011 Share Award Plan. (F1) All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 14, 2026. |
| 3 | Common | Ordinary Shares | 2026-09-14 | M | A | 5,000 | $5.93 | 11,266 | D | — | — | (F1) All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 14, 2026. |
| 4 | Common | Ordinary Shares | 2026-09-14 | F | D | 1,371 | $8.36 | 6,266 | D | — | — | (F3) Represents a "net exercise" of outstanding stock options. The reporting person received 1,371 ordinary shares on net exercise of option to purchase 5,000 ordinary shares. The Company withheld 3,629 ordinary shares underlying the option for payment of the exercise price and tax withholdings, using the closing stock price on September 14, 2026 of $8.36, pursuant to the terms of the Company's 2011 Share Award Plan. (F1) All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 14, 2026. |
| 5 | Common | Ordinary Shares | 2026-09-14 | M | A | 5,000 | $5.93 | 11,266 | D | — | — | (F1) All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 14, 2026. |
| 6 | Common | Ordinary Shares | 2026-09-14 | F | D | 1,371 | $8.36 | 6,266 | D | — | — | (F4) Represents a "net exercise" of outstanding stock options. The reporting person received 1,371 ordinary shares on net exercise of option to purchase 5,000 ordinary shares. The Company withheld 3,629 ordinary shares underlying the option for payment of the exercise price and tax withholdings, using the closing stock price on September 14, 2026 of $8.36, pursuant to the terms of the Company's 2011 Share Award Plan. (F1) All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 14, 2026. |
| 7 | Common | Ordinary Shares | 2026-09-14 | M | A | 6,500 | $5.93 | 12,766 | D | — | — | (F1) All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 14, 2026. |
| 8 | Common | Ordinary Shares | 2026-09-14 | F | D | 1,783 | $8.36 | 6,266 | D | — | — | (F5) Represents a "net exercise" of outstanding stock options. The reporting person received 1,783 ordinary shares on net exercise of option to purchase 6,500 ordinary shares. The Company withheld 4,717 ordinary shares underlying the option for payment of the exercise price and tax withholdings, using the closing stock price on September 14, 2026 of $8.36, pursuant to the terms of the Company's 2011 Share Award Plan. (F1) All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 14, 2026. |
| 9 | Common | Ordinary Shares | 2026-09-14 | M | A | 5,464 | $5.93 | 11,730 | D | — | — | (F1) All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 14, 2026. |
| 10 | Common | Ordinary Shares | 2026-09-14 | F | D | 1,499 | $8.35 | 6,266 | D | — | — | (F6) Represents a "net exercise" of outstanding stock options. The reporting person received 1,499 ordinary shares on net exercise of option to purchase 5,464 ordinary shares. The Company withheld 3,965 ordinary shares underlying the option for payment of the exercise price and tax withholdings, using the closing stock price on September 14, 2026 of $8.35, pursuant to the terms of the Company's 2011 Share Award Plan. (F1) All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 14, 2026. |
| 11 | Derivative | Employee Stock Option (right to buy) | 2026-09-14 | M | D | 5,000 | $0.00 | 0 | I Held by trustee | $5.93 · — to — | 5,000 Ordinary Shares | (F1) All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 14, 2026. (F7) Options vested in four equal installments, with 25% vested on each of the four anniversaries of the date of grant. (F7) Options vested in four equal installments, with 25% vested on each of the four anniversaries of the date of grant. (F8) Held by trustee under the Company's 2011 Share Award Plan. |
| 12 | Derivative | Employee Stock Option (right to buy) | 2026-09-14 | M | D | 5,000 | $0.00 | 0 | I Held by trustee | $5.93 · — to — | 5,000 Ordinary Shares | (F1) All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 14, 2026. (F7) Options vested in four equal installments, with 25% vested on each of the four anniversaries of the date of grant. (F7) Options vested in four equal installments, with 25% vested on each of the four anniversaries of the date of grant. (F8) Held by trustee under the Company's 2011 Share Award Plan. |
| 13 | Derivative | Employee Stock Option (right to buy) | 2026-09-14 | M | D | 5,000 | $0.00 | 0 | I Held by trustee | $5.93 · — to — | 5,000 Ordinary Shares | (F1) All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 14, 2026. (F7) Options vested in four equal installments, with 25% vested on each of the four anniversaries of the date of grant. (F7) Options vested in four equal installments, with 25% vested on each of the four anniversaries of the date of grant. (F8) Held by trustee under the Company's 2011 Share Award Plan. |
| 14 | Derivative | Employee Stock Option (right to buy) | 2026-09-14 | M | D | 6,500 | $0.00 | 0 | I Held by trustee | $5.93 · — to — | 6,500 Ordinary Shares | (F1) All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 14, 2026. (F7) Options vested in four equal installments, with 25% vested on each of the four anniversaries of the date of grant. (F7) Options vested in four equal installments, with 25% vested on each of the four anniversaries of the date of grant. (F8) Held by trustee under the Company's 2011 Share Award Plan. |
| 15 | Derivative | Employee Stock Option (right to buy) | 2026-09-14 | M | D | 5,464 | $0.00 | 0 | I Held by trustee | $5.93 · — to — | 5,464 Ordinary Shares | (F1) All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 14, 2026. (F7) Options vested in four equal installments, with 25% vested on each of the four anniversaries of the date of grant. (F7) Options vested in four equal installments, with 25% vested on each of the four anniversaries of the date of grant. (F8) Held by trustee under the Company's 2011 Share Award Plan. |